Psychiatry Won’t Pull Paper on Misleading Safety of PAXIL, Despite Massive Drug Settlement, Consumers Get “Expression of Concern” May 1, 2026
Executive Order Driven Off‑Label Behavioral Health: Nothing to Measure, Now Reaching for Street Drugs April 26, 2026
The Pill Before the Kill: Psychiatry as Dealer, Defender, and Judge of Its Own Patients April 18, 2026
Identity as a Diagnosis: How Psychiatric Power Redefines Reality & Dodges Accountability February 15, 2026
AbleChild Demands Congressional Support for Informed Consent with EXIT Plans for Consumers Relating to Psychiatric Labels & Drugs in 2026 January 1, 2026
